Verismo Therapeutics to Present Novel Multi-chain KIR-CAR Data – Including Initial Clinical Trial Results for Lead Immuno-Oncology Candidates SynKIR™-110 and SynKIR™-310 – at AACR Annual Meeting 2026

Author: Verismo Therapeutics

Posted Date: